Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dyspareunia | 1 | 2001 | 7 | 0.180 |
Why?
|
| Vulvar Diseases | 1 | 2001 | 12 | 0.180 |
Why?
|
| Biofeedback, Psychology | 1 | 2001 | 34 | 0.180 |
Why?
|
| Electromyography | 1 | 2001 | 164 | 0.170 |
Why?
|
| Exercise Therapy | 1 | 2001 | 162 | 0.160 |
Why?
|
| Pain | 1 | 2001 | 453 | 0.140 |
Why?
|
| Placenta Diseases | 1 | 2016 | 59 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2016 | 142 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 136 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 125 | 0.120 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2016 | 90 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 980 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 162 | 0.110 |
Why?
|
| Placenta | 1 | 2016 | 513 | 0.090 |
Why?
|
| Pulmonary Blastoma | 1 | 2010 | 11 | 0.090 |
Why?
|
| Genome, Human | 1 | 2016 | 1304 | 0.080 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2005 | 17 | 0.060 |
Why?
|
| Proline | 1 | 2005 | 79 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 143 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 1029 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2001 | 33 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1668 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2001 | 345 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2016 | 76 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 149 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 574 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2016 | 530 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 364 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 655 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1615 | 0.020 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2010 | 20 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 900 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8302 | 0.020 |
Why?
|
| Female | 4 | 2016 | 67310 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 1251 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2010 | 607 | 0.020 |
Why?
|
| Humans | 5 | 2016 | 126285 | 0.020 |
Why?
|
| Carbon-Nitrogen Lyases | 1 | 2005 | 2 | 0.020 |
Why?
|
| SUMO-1 Protein | 1 | 2005 | 8 | 0.020 |
Why?
|
| Hydrolases | 1 | 2005 | 56 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2001 | 12379 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2005 | 116 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1909 | 0.010 |
Why?
|
| Glycine | 1 | 2005 | 168 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7257 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1749 | 0.010 |
Why?
|
| Middle Aged | 1 | 2001 | 27028 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 3118 | 0.010 |
Why?
|
| Adult | 1 | 2001 | 29791 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 3040 | 0.010 |
Why?
|
| Male | 2 | 2016 | 62009 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 12667 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 5956 | 0.010 |
Why?
|